In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Jean-Philippe Collet
Speaker
Jean-Philippe Collet
Jean-Philippe Collet Jean-Philippe Collet

Sorbonne Universite Pitie Salpetriere Hospital, Paris (France)

Specialities : Interventional Cardiology , Acute Coronary Syndromes, Pharmacology and Pharmacotherapy

Dr Jean-Philippe Collet is a Professor of Cardiology at Pitié-Salpêtrière Hospital (APHP) where he leads the interventional catheterization unit (PCI and TAVI). He is also the director of Cardiovascular Training Program at Sorbonne Université. His main expertise is in the field of thrombosis, the effect of antithrombotic agents and the development of new devices for structural heart intervention. He is a member and a founder of the Academic Research Organisation A.C.T.I.O.N (Alliés in Cardiovascular Trials, Initiatives and Organized Networks) (www.action-coeur.org). He has led clinical trials as a principal investigator (AMERICA, DOSAPI, ARCTIC and ATLANTIS). He has several commitments in the ESC. He is a Fellow of the European Society of Cardiology, a member of the nucleus of the WG Thrombosis and a member of the Clinical Practice Guidelines Committee. He has served as the Chair of the EAPCI scientific program for two years and is now co-chairing the upcoming guidelines on NSTE-ACS.

34 presentations from this speaker

2020 ESC Guidelines on Non-ST-Segment Elevation Acute Coronary Syndromes.

Event : ESC Asia 2020

  • Session : 2020 ESC Guidelines on Non-ST-Segment Elevation Acute Coronary Syndromes
  • Speaker : JP Collet (Paris,FR), JWC Tan (Singapore,SG), K Park (Seoul,KR)

2020 NSTE-ACS ESC Guidelines: implications for practice.

Event : Webinar 2020

  • Session : ESC Webinars 2020
  • Speaker : S Leonardi (Pavia,IT), M Rubini Gimenez (Leipzig,DE), JP Collet (Paris,FR)

Short-term dual antiplatelet therapy is safe and effective after PCI - CON.

Event : ESC Congress 2020

  • Session : Controversies in Antiplatelet Treatment: Is Short-Term Dual Antiplatelet Therapy Safe and Effective after PCI?
  • Speaker : JP Collet (Paris,FR)

STEMI patient with multivessel disease - Conclusion and take home message.

Event : ESC Congress 2019

  • Session : Guidelines in Practice - Revascularisation strategies in STEMI and multivessel disease
  • Speaker : JP Collet (Paris,FR)
  • Guidelines in Daily Practice

Sudden cardiac death during Endurance Races: is it always preventable?

Event : ESC Congress 2019

  • Session : Late Breaking Science in Arrhythmias
  • Speaker : JP Collet (Paris,FR)

There is still a place for thrombolysis in myocardial infarction - CON.

Event : ESC Congress 2019

  • Session : Emergency medicine: the French touch
  • Speaker : JP Collet (Paris,FR)

Anticoagulation should replace antiplatelets in CAD prevention - CON

Event : ESC Congress 2018

  • Session : The great debate: thrombocardiology post COMPASS.
  • Speaker : JP Collet (Paris,FR)
  • Great Debate

Anticoagulation should replace antiplatelets in CAD prevention - Rebuttal CON.

Event : ESC Congress 2018

  • Session : The great debate: thrombocardiology post COMPASS.
  • Speaker : JP Collet (Paris,FR)
  • Great Debate

Antithrombotic therapy after INFRA - Popliteal stenting for critical limb-threatening ischemia - What do the guidelines say?

Event : ESC Congress 2018

  • Session : Antithrombotic therapy in patients with lower extremity arterial disease
  • Speaker : JP Collet (Paris,FR)

Clinical trials in atrial fibrillation with acute coronary syndrome or stenting: triple vs dual therapy: more benefit or more trouble?

Event : ESC Congress 2018

  • Session : Atrial fibrillation in the context of acute coronary syndromes and coronary intervention: what should we do?
  • Speaker : JP Collet (Paris,FR)

FRANCE-TAVI registry - Anti-thrombotic treatment after TAVR

Event : ESC Congress 2018

  • Session : Late Breaking Science in Interventional Cardiology 1
  • Speaker : JP Collet (Paris,FR)

Myocardial revascularization in patients with acute coronary syndromes.

Event : ESC Congress 2018

  • Session : 2018 ESC/EACTS Guidelines on Myocardial Revascularisation
  • Speaker : JP Collet (Paris,FR)

AMI-STEMI.

Event : ESC Congress 2017

  • Session : Congress Condensed - ESC Clinical Practice Guidelines 2017
  • Speaker : JP Collet (Paris,FR)

General prevention and antithrombotic therapies.

Event : ESC Congress 2017

  • Session : ESC Guidelines 2017 - Diagnosis and treatment of peripheral arterial diseases,in collaboration with the ESVS
  • Speaker : JP Collet (Paris,FR), L Mazzolai (Lausanne,CH)

NOACs vs vitamine K antagonist in patients with extreme body weights.

Event : ESC Congress 2017

  • Session : The use of oral anticoagulants in special situations
  • Speaker : JP Collet (Paris,FR)

Patients with coronary artery disease should be screened for peripheral vascular disease - CON

Event : ESC Congress 2017

  • Session : Debates in peripheral vascular disease
  • Speaker : JP Collet (Paris,FR)

Hot topics in the current Guidelines

Event : ESC Congress 2016

  • Session : Advances in myocardial revascularisation
  • Speaker : JP Collet (Paris,FR)

Interruption of antiplatelet therapy: benefits and risks

Event : ESC Congress 2016

  • Session : Bridging of antithrombotic therapy for invasive procedure
  • Speaker : JP Collet (Paris,FR)

State of the art in platelet P2Y12 iinhibition in acute coronary syndromes

Event : ESC Congress 2016

  • Session : Rapid platelet P2Y12 iinhibition in acute coronary syndromes
  • Speaker : JP Collet (Paris,FR)

Antithrombotic treatment.

Event : ESC Congress 2015

  • Session : ESC Guidelines - Acute Coronary Syndromes Non-ST-Elevation
  • Speaker : JP Collet (Paris,FR)

Prasugrel is best suited with potent and irreversible P2Y12.

Event : ESC Congress 2015

  • Session : Which is the best partner for aspirin in treatment of acute coronary syndromes?
  • Speaker : JP Collet (Paris,FR)

Antithrombotic therapy in patients undergoing revascularization.

Event : ESC Congress 2014

  • Session : ESC/EACTS Guidelines on myocardial revascularization
  • Speaker : JP Collet (Paris,FR)

Antithrombotics - which drugs?

Event : ESC Congress 2014

  • Session : Pre-hospital diagnosis and management of acute coronary syndrome
  • Speaker : JP Collet (Paris,FR)

Combined aortic stenosis and coronary artery disease: conclusion and general take home message.

Event : ESC Congress 2014

  • Session : Combined aortic stenosis and coronary artery disease: a treacherous combination
  • Speaker : JP Collet (Paris,FR)

Effect of coronary revascularisation on survival of patients with acute myocardial infarction and shock on ECMO

Event : ESC Congress 2014

  • Session : Cardiogenic shock and cardiac arrest
  • Speaker : JP Collet (Paris,FR)

Selective use of platelet glycoprotein IIb/IIIa inhibition + case discussion.

Event : ESC Congress 2014

  • Session : 20 years clinical use of GP IIb/IIIa receptor antagonists: what have we learned and where to go?
  • Speaker : JP Collet (Paris,FR)
  • Organised by Leiden University Medical Centre / Course Director: Wouter Jukema / Supported by an unrestricted educational grant from Physicians’ Academy for Cardiovascular Education

Upstream versus intraprocedural antiplatelet therapy.

Event : ESC Congress 2014

  • Session : Hot topics in STEMI interventions
  • Speaker : JP Collet (Paris,FR)

ARCTIC-GENE: ARCTIC-GENE

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line III: Updates on risk and outcome
  • Speaker : JP Collet (Paris,FR)

Bleeding in a patient with triple antithrombotic therapy.

Event : ESC Congress 2013

  • Session : Challenging cases in acute coronary syndromes
  • Speaker : JP Collet (Paris,FR)

High on-treatment platelet reactivity, a marker of bleeding risk? an analysis of the ARCTIC study

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : JP Collet (Paris,FR)

Pro.

Event : ESC Congress 2013

  • Session : Platelet response testing should be abandoned.
  • Speaker : JP Collet (Paris,FR)

Pro.

Event : ESC Congress 2013

  • Session : Platelet response testing should be abandoned.
  • Speaker : JP Collet (Paris,FR)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are